ALFACALCIDOL CAPSULES 0.25 MCG
ALFACALCIDOL : 0.25 MCG · DIN 02523051 · STRIDES PHARMA CANADA INC
Health Canada status: APPROVED
What is ALFACALCIDOL CAPSULES?
ALFACALCIDOL CAPSULES 0.25 MCG contains ALFACALCIDOL : 0.25 MCG. It is listed in the Health Canada Drug Product Database under DIN 02523051, held by STRIDES PHARMA CANADA INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as approved, status dated 06-Dec-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02523051 |
|---|---|
| Brand name | ALFACALCIDOL CAPSULES |
| Generic / active ingredient | ALFACALCIDOL : 0.25 MCG |
| Manufacturer | STRIDES PHARMA CANADA INC |
| Strength | 0.25 MCG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A11CC03 ALFACALCIDOL |
| AHFS class | 88:16.00 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 06-Dec-2021 |
What can be used instead?
Other Canadian products sharing ATC code A11CC03 ALFACALCIDOL. 6 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ONE-ALPHA | 0.25 MCG | CAPSULE | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 00474517 |
| ONE-ALPHA | 1 MCG | CAPSULE | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 00474525 |
| ONE-ALPHA | 2 MCG | DROPS | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 02240329 |
| ONE-ALPHA | 2 MCG | SOLUTION | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 02242502 |
| SANDOZ ALFACALCIDOL | 0.25 MCG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02533316 |
| SANDOZ ALFACALCIDOL | 1 MCG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02533324 |
| ALFACALCIDOL CAPSULES | 1 MCG | CAPSULE | STRIDES PHARMA CANADA INC | APPROVED | DIN 02523078 |
| ONE-ALPHA | 0.5 MCG | CAPSULE | LEO PHARMA INC | CANCELLED PRE MARKET | DIN 02239431 |
| ONE-ALPHA SOL 0.2MCG/ML | .2 MCG | LIQUID | LEO PHARMA INC | CANCELLED POST MARKET | DIN 00759546 |
Who else supplies ALFACALCIDOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ALFACALCIDOL appears in 63 registered pack listings across 12 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.